MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ∗

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lü, Mingrong ^a,b   Ding, Keshuo ^a,b,c   Zhang, Guofeng ^d   Yin, Mianmian ^a,b   Yao, Guidong ^e   Tian, Hui ^a,b   Lian, Jie ^a,b   Liu, Lin ^a,b   Liang, Meng ^a,b   Zhu, Tao ^a,b   Sun, Fei ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d TONGJI UNIVERSITY   (China)

^e THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CYCLIC AMP-REGULATED PHOSPHOPROTEIN 19; ESRRG PROTEIN, HUMAN; ESTROGEN; ESTROGEN RECEPTOR; MICRORNA; MIRN320 MICRORNA, HUMAN; MYC PROTEIN; PHOSPHOPROTEIN; PROGESTERONE; TAMOXIFEN;

ANIMAL; BREAST NEOPLASMS; CELL SURVIVAL; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; MCF-7 CELL LINE; METABOLISM; NUDE MOUSE; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MCF-7 CELLS; MICE, NUDE; MICRORNAS; PHOSPHOPROTEINS; PROGESTERONE; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAMOXIFEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84930005126     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08735     Document Type: Article

References (32)

1. Lee, Y. J. et al. Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells. INTERNATIONAL JOURNAL OF MEDIC 9, 881-893 (2012).
2. Riggins, R. B. et al. ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res 68, 8908-8917 (2008).
3. Ward, A. et al. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 32, 1173-1182, doi:10.1038/onc.2012.128 (2013).
4. Musgrove, E. A. et al. Identification of functional networks of estrogen-and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. PloS one 3, e2987, doi:10.1371/journal.pone.0002987 (2008).
5. Ahnstrom,M., Nordenskjold, B., Rutqvist, L. E., Skoog, L. & Stal, O. Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance. BREAST CANCER RES Treat 91, 145-151, doi:10.1007/s10549-004-6457-4 (2005).
6. Liu, H. et al. MYC suppresses cancer metastasis by direct transcriptional silencing of alphav and beta3 integrin subunits. Nat Cell Biol 14, 567-574, doi:10.1038/ ncb2491 (2012).
7. Garcia-Becerra, R., Santos, N., Diaz, L. & Camacho, J. Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance. INT J MOL SCI 14, 108-145, doi:10.3390/ ijms14010108 (2012).
8. Kasinski, A. L. & Slack, F. J. Epigenetics and genetics. MicroRNAs enroute to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11, 849-864, doi:10.1038/nrc3166 (2011).
9. Cittelly, D. M. et al. Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol Cancer 9, 317, doi:10.1186/1476-4598-9-317 (2010).
10. Calin, G. A. et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. PNAS 101, 2999-3004, doi:10.1073/ pnas.0307323101 (2004).
11. Miller, T. E. et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. JBC 283, 29897-29903, doi:10.1074/ jbc.M804612200 (2008).
12. Zhao, Y. et al. let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor alpha signaling in breast cancer. MOL MED 17, 1233-1241, doi:10.2119/molmed.2010.00225 (2011).
13. Yao, G. et al. MicroRNA-224 is involved in transforming growth factor-betamediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol 24, 540-551, doi:10.1210/me.2009-0432 (2010).
14. Yin, M. et al. Transactivation of miR-320 by miR-383 regulates granulosa cell functions by targeting E2F1 and SF-1∗. JBC 289, doi:10.1074/jbc.M113.546044 (2014).
15. White, R. E. & Giffard, R. G. MicroRNA-320 induces neurite outgrowth by targeting ARPP-19. Neuroreport 23, 590-595, doi:10.1097/ WNR.0b013e3283540394 (2012).
16. Girault, J. A., Horiuch, A., Gustafson, E. L., Rosen, N. L. & Greengard, P. Differential expression of ARPP-16 and ARPP-19, two highly related CAMPregulated phosphoproteins, one of which Is specifically associated with dopamine-innervated brain regions. J NEUROSCI 10, 1124-1133 (1990).
17. Haccard, O. & Jessus, C. Greatwall kinase, ARPP-19 and protein phosphatase 2A: shifting the mitosis paradigm. Springer 53, 219-234, doi:10.1007/978-3-642-19065-0-11 (2011).
18. Miller, T. W. et al. A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance. Clin Cancer Res 17, 2024-2034, doi:10.1158/1078-0432.CCR-10-2567 (2011).
19. Xia, H. F. et al. Temporal and spatial regulation of miR-320 in the uterus during embryo implantation in the rat. INT J MOL SCI 11, 719-730, doi:10.3390/ ijms11020719 (2010).
20. K, L. F. et al. Rapid regulation of c-myc protooncogene expression by progesterone in the avian oviduct. Proc. Nad. Acad. Sci. 85, 4 (1987).
21. Jin, K. et al. The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. PNAS 109, 2736-2741, doi:10.1073/ pnas.1018859108 (2012).
22. Perillo, B., Sasso, A., Abbondanza, C. & Palumbo, G. 17ß-Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding Sequence. MOL AND CELL Biol 20, 2890-2901 (2000).
23. Bronisz, A. et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. NAT CELL BIOL 14, 159-167, doi:10.1038/ncb2396 (2012).
24. Schepeler, T. et al. Diagnostic and prognostic microRNAs in stage II colon cancer. CANCER RES 68, 6416-6424, doi:10.1158/0008-5472.CAN-07-6110 (2008).
25. Planas-Silva, M. D., Bruggeman, R. D.,Grenko, R. T.&Smith, J. S.Overexpression of c-Myc and Bcl-2 during progression and distantmetastasis of hormone-treated breast cancer. EXP MOL PATHOL 82, 85-90, doi:10.1016/j.yexmp.2006.09.001 (2007).
26. Bostner, J. et al. Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. Oncogene 26, 6997-7005, doi:10.1038/sj.onc.1210506 (2007).
27. Holm, C. et al. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. J Natl Cancer Inst 98, 671-680, doi:10.1093/jnci/djj185 (2006).
28. Masafumi Koga, E. A. M. a. R. L. S. Modulation of the Growth-inhibitory Effects of Progestins and the Antiestrogen Hydroxyclomiphene on Human Breast Cancer Cells by Epidermal Growth Factor and Insulin.pdf. CANCER RES 49, 49:112-116 (1989).
29. Liu, L. et al. MicroRNA-302a sensitizes testicular embryonal carcinoma cells to cisplatin-induced cell death. J CELL PHYSIOL 228, 2294-2304, doi:10.1002/ jcp.24394 (2013).
30. Yin, M. et al. Transactivation of microRNA-383 by steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1. Mol Endocrinol 26, 1129-1143, doi:10.1210/me.2011-1341 (2012).
31. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDC T Method. Methods 25, 402-408, doi:10.1006/meth.2001.1262 (2001).
32. Qian, P. et al. Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. CANCER RES 71, 6463-6474, doi:10.1158/0008-5472.CAN-11-1322 (2011).